These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7769922)

  • 1. False positives and negatives in routine testing for drugs of abuse.
    Forrest AR
    Lancet; 1995 Jun; 345(8963):1510-1. PubMed ID: 7769922
    [No Abstract]   [Full Text] [Related]  

  • 2. False positives and negatives in routine testing for drugs of abuse.
    Notarianni LJ; Belk D; Collins AJ
    Lancet; 1995 Apr; 345(8957):1115. PubMed ID: 7715360
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
    Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of interferences for gas chromatography/mass spectrometry analysis of urine for drugs of abuse.
    Wu AH
    Ann Clin Lab Sci; 1995; 25(4):319-29. PubMed ID: 7668815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine opioid screens may be misleading.
    Rubingh C
    J Pain Palliat Care Pharmacother; 2002; 16(2):103-4. PubMed ID: 14650466
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of ketamine and norketamine in hair by gas chromatography/mass spectrometry using two-step derivatization.
    Kim JY; In MK; Kim JH
    Rapid Commun Mass Spectrom; 2006; 20(20):3159-62. PubMed ID: 16989007
    [No Abstract]   [Full Text] [Related]  

  • 8. Random mandatory drugs testing of prisoners.
    Bird SM
    Lancet; 2005 Apr 23-29; 365(9469):1451-2. PubMed ID: 15850619
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Drugs of Abuse by Gas Chromatography-Mass Spectrometry (GC-MS).
    Brettell TA; Lum BJ
    Methods Mol Biol; 2018; 1810():29-42. PubMed ID: 29974415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Workplace testing of drugs of abuse and psychotropic drugs].
    Mura P; Saussereau E; Brunet B; Goullé JP
    Ann Pharm Fr; 2012 May; 70(3):120-32. PubMed ID: 22655580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department.
    Johnson-Davis KL; Thompson CD; Clark CJ; McMillin GA; Lehman CM
    J Anal Toxicol; 2012 Jun; 36(5):345-8. PubMed ID: 22582270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive cannabis results in Italian workplace drug testing.
    Fucci N; De Giovanni N
    Drug Test Anal; 2012 Feb; 4(2):71-3. PubMed ID: 22362572
    [No Abstract]   [Full Text] [Related]  

  • 16. Special issue on illicit drugs.
    Brandt SD
    Drug Test Anal; 2011 Sep; 3(9):525-6. PubMed ID: 21960537
    [No Abstract]   [Full Text] [Related]  

  • 17. Addressing the challenges in forensic drug chemistry.
    Brandt SD; Kavanagh PV
    Drug Test Anal; 2017 Mar; 9(3):342-346. PubMed ID: 28103651
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry.
    Moody DE; Fang WB; Andrenyak DM; Monti KM; Jones C
    J Anal Toxicol; 2006; 30(1):50-6. PubMed ID: 16620532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Special issue on the 7th Symposium of the EWDTS on Workplace Drug Testing.
    Agius R
    Drug Test Anal; 2012 Feb; 4(2):59-61. PubMed ID: 22362569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.